Contents
Issue 150 • January 2025
In association with
In Depth
US reproductive laws could limit women’s participation in clinical trials
How Pfizer management outplayed activist investor Starboard
Trump 2.0 spells global change in pharmaceutical regulation, funding and investment
Flu vaccine strategy on the line as new US leaders anticipated to take charge
Lilly’s £279m bet aims to boost UK life sciences sector
PrEP therapies offer new hope in HIV preventive landscape as vaccine failures amas